Dr. Mamatha Pasnoor, a valued member of the Global Medical Advisory Board, discusses HYQVIA®, a newly FDA-approved treatment option for CIDP. Developed by Takeda, this innovative therapy marks a significant step forward in care for those affected by CIDP.
